nodes	percent_of_prediction	percent_of_DWPC	metapath
Triamterene—hypertension—type 2 diabetes mellitus	0.573	1	CtDrD
Triamterene—CYP1A2—type 2 diabetes mellitus	0.201	1	CbGaD
Triamterene—CYP1A2—Rosiglitazone—type 2 diabetes mellitus	0.0209	0.329	CbGbCtD
Triamterene—CYP1A2—Irbesartan—type 2 diabetes mellitus	0.0165	0.259	CbGbCtD
Triamterene—CYP1A2—Bromocriptine—type 2 diabetes mellitus	0.0156	0.245	CbGbCtD
Triamterene—CYP1A2—Losartan—type 2 diabetes mellitus	0.0106	0.167	CbGbCtD
Triamterene—SCNN1A—islet of Langerhans—type 2 diabetes mellitus	0.00213	0.104	CbGeAlD
Triamterene—SCNN1G—kidney—type 2 diabetes mellitus	0.00193	0.0938	CbGeAlD
Triamterene—SCNN1G—cortex of kidney—type 2 diabetes mellitus	0.00188	0.0914	CbGeAlD
Triamterene—SCNN1A—nephron tubule—type 2 diabetes mellitus	0.00172	0.0833	CbGeAlD
Triamterene—SCNN1B—kidney—type 2 diabetes mellitus	0.00163	0.0793	CbGeAlD
Triamterene—SCNN1B—cortex of kidney—type 2 diabetes mellitus	0.00159	0.0772	CbGeAlD
Triamterene—SCNN1A—kidney—type 2 diabetes mellitus	0.00151	0.0732	CbGeAlD
Triamterene—SCNN1A—pancreas—type 2 diabetes mellitus	0.0015	0.0728	CbGeAlD
Triamterene—SCNN1B—adipose tissue—type 2 diabetes mellitus	0.00147	0.0715	CbGeAlD
Triamterene—SCNN1A—cortex of kidney—type 2 diabetes mellitus	0.00147	0.0713	CbGeAlD
Triamterene—SCNN1A—adipose tissue—type 2 diabetes mellitus	0.00136	0.066	CbGeAlD
Triamterene—SCNN1D—liver—type 2 diabetes mellitus	0.00122	0.0593	CbGeAlD
Triamterene—SCNN1A—liver—type 2 diabetes mellitus	0.000954	0.0463	CbGeAlD
Triamterene—Jaundice—Acarbose—type 2 diabetes mellitus	0.000808	0.00952	CcSEcCtD
Triamterene—Jaundice—Nateglinide—type 2 diabetes mellitus	0.000779	0.00918	CcSEcCtD
Triamterene—Renal failure acute—Sitagliptin—type 2 diabetes mellitus	0.000749	0.00882	CcSEcCtD
Triamterene—Tubulointerstitial nephritis—Irbesartan—type 2 diabetes mellitus	0.000729	0.00859	CcSEcCtD
Triamterene—Tubulointerstitial nephritis—Losartan—type 2 diabetes mellitus	0.000686	0.00808	CcSEcCtD
Triamterene—Jaundice—Repaglinide—type 2 diabetes mellitus	0.000675	0.00795	CcSEcCtD
Triamterene—Blood urea increased—Gliclazide—type 2 diabetes mellitus	0.000668	0.00787	CcSEcCtD
Triamterene—Hyperkalaemia—Valsartan—type 2 diabetes mellitus	0.000639	0.00752	CcSEcCtD
Triamterene—Renal failure acute—Glyburide—type 2 diabetes mellitus	0.000619	0.0073	CcSEcCtD
Triamterene—Blood urea increased—Valsartan—type 2 diabetes mellitus	0.000614	0.00723	CcSEcCtD
Triamterene—Thrombocytopenia—Tolbutamide—type 2 diabetes mellitus	0.000592	0.00698	CcSEcCtD
Triamterene—Photosensitivity reaction—Glipizide—type 2 diabetes mellitus	0.000586	0.0069	CcSEcCtD
Triamterene—Photosensitivity—Gliclazide—type 2 diabetes mellitus	0.000585	0.00689	CcSEcCtD
Triamterene—Jaundice—Glipizide—type 2 diabetes mellitus	0.000558	0.00657	CcSEcCtD
Triamterene—Renal failure acute—Gliclazide—type 2 diabetes mellitus	0.000556	0.00655	CcSEcCtD
Triamterene—Hyperkalaemia—Irbesartan—type 2 diabetes mellitus	0.000549	0.00646	CcSEcCtD
Triamterene—Photosensitivity reaction—Glimepiride—type 2 diabetes mellitus	0.000547	0.00644	CcSEcCtD
Triamterene—Anaphylactic shock—Linagliptin—type 2 diabetes mellitus	0.000545	0.00642	CcSEcCtD
Triamterene—Thrombocytopenia—Tolazamide—type 2 diabetes mellitus	0.000539	0.00635	CcSEcCtD
Triamterene—Thrombocytopenia—Chlorpropamide—type 2 diabetes mellitus	0.000539	0.00635	CcSEcCtD
Triamterene—Photosensitivity—Valsartan—type 2 diabetes mellitus	0.000537	0.00633	CcSEcCtD
Triamterene—Blood urea increased—Irbesartan—type 2 diabetes mellitus	0.000527	0.00621	CcSEcCtD
Triamterene—Jaundice—Glimepiride—type 2 diabetes mellitus	0.000521	0.00613	CcSEcCtD
Triamterene—Thrombocytopenia—Acarbose—type 2 diabetes mellitus	0.000518	0.0061	CcSEcCtD
Triamterene—Hyperkalaemia—Losartan—type 2 diabetes mellitus	0.000516	0.00608	CcSEcCtD
Triamterene—Renal failure acute—Valsartan—type 2 diabetes mellitus	0.000511	0.00602	CcSEcCtD
Triamterene—Blood urea increased—Losartan—type 2 diabetes mellitus	0.000496	0.00584	CcSEcCtD
Triamterene—Fatigue—Tolazamide—type 2 diabetes mellitus	0.000475	0.00559	CcSEcCtD
Triamterene—Photosensitivity—Irbesartan—type 2 diabetes mellitus	0.000462	0.00544	CcSEcCtD
Triamterene—Diarrhoea—Miglitol—type 2 diabetes mellitus	0.00046	0.00542	CcSEcCtD
Triamterene—Photosensitivity reaction—Glyburide—type 2 diabetes mellitus	0.000451	0.00531	CcSEcCtD
Triamterene—Anaphylactic shock—Repaglinide—type 2 diabetes mellitus	0.000441	0.0052	CcSEcCtD
Triamterene—Fatigue—Nateglinide—type 2 diabetes mellitus	0.00044	0.00518	CcSEcCtD
Triamterene—Photosensitivity—Losartan—type 2 diabetes mellitus	0.000435	0.00512	CcSEcCtD
Triamterene—Thrombocytopenia—Repaglinide—type 2 diabetes mellitus	0.000432	0.00509	CcSEcCtD
Triamterene—Jaundice—Glyburide—type 2 diabetes mellitus	0.00043	0.00506	CcSEcCtD
Triamterene—Blood urea increased—Ramipril—type 2 diabetes mellitus	0.000426	0.00501	CcSEcCtD
Triamterene—Rash—Miglitol—type 2 diabetes mellitus	0.000424	0.005	CcSEcCtD
Triamterene—Hypokalaemia—Orlistat—type 2 diabetes mellitus	0.000424	0.005	CcSEcCtD
Triamterene—Dermatitis—Miglitol—type 2 diabetes mellitus	0.000424	0.00499	CcSEcCtD
Triamterene—Anaphylactic shock—Rosiglitazone—type 2 diabetes mellitus	0.000417	0.00491	CcSEcCtD
Triamterene—Thrombocytopenia—Rosiglitazone—type 2 diabetes mellitus	0.000409	0.00481	CcSEcCtD
Triamterene—Photosensitivity reaction—Gliclazide—type 2 diabetes mellitus	0.000405	0.00477	CcSEcCtD
Triamterene—Hypersensitivity—Linagliptin—type 2 diabetes mellitus	0.000401	0.00473	CcSEcCtD
Triamterene—Nausea—Miglitol—type 2 diabetes mellitus	0.0004	0.00471	CcSEcCtD
Triamterene—Asthenia—Tolazamide—type 2 diabetes mellitus	0.000395	0.00465	CcSEcCtD
Triamterene—Hypersensitivity—Acarbose—type 2 diabetes mellitus	0.00039	0.00459	CcSEcCtD
Triamterene—Jaundice—Gliclazide—type 2 diabetes mellitus	0.000386	0.00454	CcSEcCtD
Triamterene—Rash—Tolbutamide—type 2 diabetes mellitus	0.000382	0.00449	CcSEcCtD
Triamterene—Headache—Tolbutamide—type 2 diabetes mellitus	0.000379	0.00446	CcSEcCtD
Triamterene—Diarrhoea—Chlorpropamide—type 2 diabetes mellitus	0.000377	0.00444	CcSEcCtD
Triamterene—Hypersensitivity—Nateglinide—type 2 diabetes mellitus	0.000376	0.00443	CcSEcCtD
Triamterene—Diarrhoea—Linagliptin—type 2 diabetes mellitus	0.000373	0.00439	CcSEcCtD
Triamterene—Photosensitivity—Ramipril—type 2 diabetes mellitus	0.000373	0.00439	CcSEcCtD
Triamterene—Photosensitivity reaction—Valsartan—type 2 diabetes mellitus	0.000372	0.00438	CcSEcCtD
Triamterene—Hypokalaemia—Irbesartan—type 2 diabetes mellitus	0.000369	0.00435	CcSEcCtD
Triamterene—Asthenia—Nateglinide—type 2 diabetes mellitus	0.000366	0.00431	CcSEcCtD
Triamterene—Dizziness—Tolazamide—type 2 diabetes mellitus	0.000364	0.00429	CcSEcCtD
Triamterene—Dizziness—Chlorpropamide—type 2 diabetes mellitus	0.000364	0.00429	CcSEcCtD
Triamterene—Diarrhoea—Acarbose—type 2 diabetes mellitus	0.000362	0.00426	CcSEcCtD
Triamterene—Fatigue—Rosiglitazone—type 2 diabetes mellitus	0.00036	0.00424	CcSEcCtD
Triamterene—Nausea—Tolbutamide—type 2 diabetes mellitus	0.000359	0.00423	CcSEcCtD
Triamterene—Thrombocytopenia—Glipizide—type 2 diabetes mellitus	0.000358	0.00421	CcSEcCtD
Triamterene—Renal failure acute—Ramipril—type 2 diabetes mellitus	0.000354	0.00417	CcSEcCtD
Triamterene—Vomiting—Chlorpropamide—type 2 diabetes mellitus	0.00035	0.00412	CcSEcCtD
Triamterene—Anaphylactic shock—Pioglitazone—type 2 diabetes mellitus	0.00035	0.00412	CcSEcCtD
Triamterene—Diarrhoea—Nateglinide—type 2 diabetes mellitus	0.000349	0.00411	CcSEcCtD
Triamterene—Dry mouth—Glimepiride—type 2 diabetes mellitus	0.000348	0.00409	CcSEcCtD
Triamterene—Rash—Chlorpropamide—type 2 diabetes mellitus	0.000347	0.00409	CcSEcCtD
Triamterene—Rash—Tolazamide—type 2 diabetes mellitus	0.000347	0.00409	CcSEcCtD
Triamterene—Dry mouth—Sitagliptin—type 2 diabetes mellitus	0.000347	0.00408	CcSEcCtD
Triamterene—Headache—Tolazamide—type 2 diabetes mellitus	0.000345	0.00406	CcSEcCtD
Triamterene—Headache—Chlorpropamide—type 2 diabetes mellitus	0.000345	0.00406	CcSEcCtD
Triamterene—Rash—Linagliptin—type 2 diabetes mellitus	0.000344	0.00405	CcSEcCtD
Triamterene—Dermatitis—Linagliptin—type 2 diabetes mellitus	0.000343	0.00404	CcSEcCtD
Triamterene—Headache—Linagliptin—type 2 diabetes mellitus	0.000341	0.00402	CcSEcCtD
Triamterene—Anaphylactic shock—Glimepiride—type 2 diabetes mellitus	0.000341	0.00401	CcSEcCtD
Triamterene—Anaphylactic shock—Sitagliptin—type 2 diabetes mellitus	0.00034	0.004	CcSEcCtD
Triamterene—Dizziness—Nateglinide—type 2 diabetes mellitus	0.000337	0.00397	CcSEcCtD
Triamterene—Vomiting—Acarbose—type 2 diabetes mellitus	0.000336	0.00396	CcSEcCtD
Triamterene—Thrombocytopenia—Glimepiride—type 2 diabetes mellitus	0.000334	0.00393	CcSEcCtD
Triamterene—Rash—Acarbose—type 2 diabetes mellitus	0.000333	0.00393	CcSEcCtD
Triamterene—Dermatitis—Acarbose—type 2 diabetes mellitus	0.000333	0.00392	CcSEcCtD
Triamterene—Nausea—Chlorpropamide—type 2 diabetes mellitus	0.000327	0.00385	CcSEcCtD
Triamterene—Nausea—Tolazamide—type 2 diabetes mellitus	0.000327	0.00385	CcSEcCtD
Triamterene—Hypersensitivity—Repaglinide—type 2 diabetes mellitus	0.000325	0.00383	CcSEcCtD
Triamterene—Vomiting—Nateglinide—type 2 diabetes mellitus	0.000324	0.00382	CcSEcCtD
Triamterene—Rash—Nateglinide—type 2 diabetes mellitus	0.000322	0.00379	CcSEcCtD
Triamterene—Dermatitis—Nateglinide—type 2 diabetes mellitus	0.000321	0.00378	CcSEcCtD
Triamterene—Photosensitivity reaction—Irbesartan—type 2 diabetes mellitus	0.00032	0.00377	CcSEcCtD
Triamterene—Nausea—Acarbose—type 2 diabetes mellitus	0.000314	0.0037	CcSEcCtD
Triamterene—Dry mouth—Bromocriptine—type 2 diabetes mellitus	0.000314	0.00369	CcSEcCtD
Triamterene—Jaundice—Irbesartan—type 2 diabetes mellitus	0.000305	0.00359	CcSEcCtD
Triamterene—Nausea—Nateglinide—type 2 diabetes mellitus	0.000303	0.00357	CcSEcCtD
Triamterene—Diarrhoea—Repaglinide—type 2 diabetes mellitus	0.000302	0.00356	CcSEcCtD
Triamterene—Fatigue—Pioglitazone—type 2 diabetes mellitus	0.000302	0.00355	CcSEcCtD
Triamterene—Photosensitivity reaction—Losartan—type 2 diabetes mellitus	0.000301	0.00355	CcSEcCtD
Triamterene—Asthenia—Rosiglitazone—type 2 diabetes mellitus	0.000299	0.00353	CcSEcCtD
Triamterene—Fatigue—Glimepiride—type 2 diabetes mellitus	0.000294	0.00346	CcSEcCtD
Triamterene—Fatigue—Sitagliptin—type 2 diabetes mellitus	0.000293	0.00345	CcSEcCtD
Triamterene—Jaundice—Losartan—type 2 diabetes mellitus	0.000287	0.00338	CcSEcCtD
Triamterene—Diarrhoea—Rosiglitazone—type 2 diabetes mellitus	0.000285	0.00336	CcSEcCtD
Triamterene—Vomiting—Repaglinide—type 2 diabetes mellitus	0.000281	0.00331	CcSEcCtD
Triamterene—Rash—Repaglinide—type 2 diabetes mellitus	0.000278	0.00328	CcSEcCtD
Triamterene—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.000278	0.00327	CcSEcCtD
Triamterene—Headache—Repaglinide—type 2 diabetes mellitus	0.000277	0.00326	CcSEcCtD
Triamterene—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.000276	0.00325	CcSEcCtD
Triamterene—Thrombocytopenia—Glyburide—type 2 diabetes mellitus	0.000275	0.00324	CcSEcCtD
Triamterene—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.000269	0.00317	CcSEcCtD
Triamterene—Fatigue—Bromocriptine—type 2 diabetes mellitus	0.000265	0.00312	CcSEcCtD
Triamterene—Rash—Rosiglitazone—type 2 diabetes mellitus	0.000263	0.0031	CcSEcCtD
Triamterene—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.000263	0.0031	CcSEcCtD
Triamterene—Nausea—Repaglinide—type 2 diabetes mellitus	0.000262	0.00309	CcSEcCtD
Triamterene—Asthenia—Glipizide—type 2 diabetes mellitus	0.000262	0.00309	CcSEcCtD
Triamterene—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000261	0.00308	CcSEcCtD
Triamterene—Photosensitivity reaction—Ramipril—type 2 diabetes mellitus	0.000258	0.00304	CcSEcCtD
Triamterene—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.000258	0.00304	CcSEcCtD
Triamterene—Dry mouth—Gliclazide—type 2 diabetes mellitus	0.000257	0.00303	CcSEcCtD
Triamterene—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.000251	0.00296	CcSEcCtD
Triamterene—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.000251	0.00296	CcSEcCtD
Triamterene—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.00025	0.00295	CcSEcCtD
Triamterene—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.00025	0.00294	CcSEcCtD
Triamterene—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000248	0.00292	CcSEcCtD
Triamterene—Thrombocytopenia—Gliclazide—type 2 diabetes mellitus	0.000247	0.00291	CcSEcCtD
Triamterene—Jaundice—Ramipril—type 2 diabetes mellitus	0.000246	0.00289	CcSEcCtD
Triamterene—Asthenia—Glimepiride—type 2 diabetes mellitus	0.000245	0.00288	CcSEcCtD
Triamterene—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.000244	0.00287	CcSEcCtD
Triamterene—Dizziness—Glipizide—type 2 diabetes mellitus	0.000242	0.00284	CcSEcCtD
Triamterene—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000239	0.00282	CcSEcCtD
Triamterene—Dry mouth—Valsartan—type 2 diabetes mellitus	0.000237	0.00279	CcSEcCtD
Triamterene—Dry mouth—Orlistat—type 2 diabetes mellitus	0.000234	0.00275	CcSEcCtD
Triamterene—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000233	0.00275	CcSEcCtD
Triamterene—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000232	0.00274	CcSEcCtD
Triamterene—Vomiting—Glipizide—type 2 diabetes mellitus	0.000232	0.00273	CcSEcCtD
Triamterene—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	0.000232	0.00273	CcSEcCtD
Triamterene—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000231	0.00272	CcSEcCtD
Triamterene—Rash—Glipizide—type 2 diabetes mellitus	0.00023	0.00271	CcSEcCtD
Triamterene—Dermatitis—Glipizide—type 2 diabetes mellitus	0.00023	0.00271	CcSEcCtD
Triamterene—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.000229	0.0027	CcSEcCtD
Triamterene—CYP1A2—liver—type 2 diabetes mellitus	0.000229	0.0111	CbGeAlD
Triamterene—Headache—Glipizide—type 2 diabetes mellitus	0.000229	0.00269	CcSEcCtD
Triamterene—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	0.000227	0.00267	CcSEcCtD
Triamterene—SCNN1B—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	0.000226	0.004	CbGpPWpGaD
Triamterene—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000225	0.00265	CcSEcCtD
Triamterene—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000225	0.00265	CcSEcCtD
Triamterene—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000221	0.0026	CcSEcCtD
Triamterene—Headache—Pioglitazone—type 2 diabetes mellitus	0.000219	0.00258	CcSEcCtD
Triamterene—SCNN1B—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	0.000219	0.00387	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	0.000219	0.00387	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	0.000219	0.00387	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	0.000219	0.00387	CbGpPWpGaD
Triamterene—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000218	0.00256	CcSEcCtD
Triamterene—Nausea—Glipizide—type 2 diabetes mellitus	0.000217	0.00255	CcSEcCtD
Triamterene—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000217	0.00255	CcSEcCtD
Triamterene—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000216	0.00254	CcSEcCtD
Triamterene—Rash—Glimepiride—type 2 diabetes mellitus	0.000215	0.00253	CcSEcCtD
Triamterene—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000215	0.00253	CcSEcCtD
Triamterene—Rash—Sitagliptin—type 2 diabetes mellitus	0.000214	0.00252	CcSEcCtD
Triamterene—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000214	0.00252	CcSEcCtD
Triamterene—Headache—Glimepiride—type 2 diabetes mellitus	0.000214	0.00251	CcSEcCtD
Triamterene—Headache—Sitagliptin—type 2 diabetes mellitus	0.000213	0.00251	CcSEcCtD
Triamterene—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.00021	0.00248	CcSEcCtD
Triamterene—SCNN1B—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	0.00021	0.00371	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	0.00021	0.00371	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	0.00021	0.00371	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	0.00021	0.00371	CbGpPWpGaD
Triamterene—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000207	0.00244	CcSEcCtD
Triamterene—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000207	0.00243	CcSEcCtD
Triamterene—CYP1A2—Tryptophan metabolism—AANAT—type 2 diabetes mellitus	0.000206	0.00364	CbGpPWpGaD
Triamterene—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000203	0.00239	CcSEcCtD
Triamterene—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000203	0.00239	CcSEcCtD
Triamterene—Nausea—Glimepiride—type 2 diabetes mellitus	0.000202	0.00238	CcSEcCtD
Triamterene—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000202	0.00238	CcSEcCtD
Triamterene—Asthenia—Glyburide—type 2 diabetes mellitus	0.000202	0.00238	CcSEcCtD
Triamterene—Fatigue—Valsartan—type 2 diabetes mellitus	0.0002	0.00235	CcSEcCtD
Triamterene—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.000199	0.00235	CcSEcCtD
Triamterene—Fatigue—Orlistat—type 2 diabetes mellitus	0.000198	0.00233	CcSEcCtD
Triamterene—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000196	0.0023	CcSEcCtD
Triamterene—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.000195	0.0023	CcSEcCtD
Triamterene—Rash—Bromocriptine—type 2 diabetes mellitus	0.000194	0.00228	CcSEcCtD
Triamterene—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000194	0.00228	CcSEcCtD
Triamterene—CYP1A2—Arachidonic acid metabolism—PTGDS—type 2 diabetes mellitus	0.000193	0.00341	CbGpPWpGaD
Triamterene—Headache—Bromocriptine—type 2 diabetes mellitus	0.000193	0.00227	CcSEcCtD
Triamterene—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000192	0.00226	CcSEcCtD
Triamterene—Dry mouth—Losartan—type 2 diabetes mellitus	0.000191	0.00225	CcSEcCtD
Triamterene—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.000188	0.00221	CcSEcCtD
Triamterene—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000186	0.00219	CcSEcCtD
Triamterene—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.000184	0.00216	CcSEcCtD
Triamterene—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000183	0.00215	CcSEcCtD
Triamterene—Fatigue—Metformin—type 2 diabetes mellitus	0.000182	0.00214	CcSEcCtD
Triamterene—SCNN1A—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	0.000182	0.00322	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	0.000182	0.00322	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	0.000182	0.00322	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	0.000182	0.00322	CbGpPWpGaD
Triamterene—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000181	0.00213	CcSEcCtD
Triamterene—Vomiting—Glyburide—type 2 diabetes mellitus	0.000179	0.0021	CcSEcCtD
Triamterene—Rash—Glyburide—type 2 diabetes mellitus	0.000177	0.00209	CcSEcCtD
Triamterene—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000177	0.00209	CcSEcCtD
Triamterene—Headache—Glyburide—type 2 diabetes mellitus	0.000176	0.00207	CcSEcCtD
Triamterene—SCNN1G—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	0.000174	0.00307	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	0.000174	0.00307	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	0.000174	0.00307	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	0.000174	0.00307	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	0.000174	0.00307	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	0.000174	0.00307	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	0.000174	0.00307	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	0.000174	0.00307	CbGpPWpGaD
Triamterene—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000173	0.00203	CcSEcCtD
Triamterene—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000172	0.00202	CcSEcCtD
Triamterene—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000171	0.00201	CcSEcCtD
Triamterene—SCNN1D—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	0.00017	0.003	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	0.00017	0.003	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	0.00017	0.003	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	0.00017	0.003	CbGpPWpGaD
Triamterene—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000169	0.00199	CcSEcCtD
Triamterene—SCNN1D—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	0.000169	0.00298	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	0.000169	0.00298	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	0.000169	0.00298	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	0.000169	0.00298	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	0.000168	0.00296	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	0.000168	0.00296	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	0.000168	0.00296	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	0.000168	0.00296	CbGpPWpGaD
Triamterene—Nausea—Glyburide—type 2 diabetes mellitus	0.000167	0.00197	CcSEcCtD
Triamterene—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000167	0.00197	CcSEcCtD
Triamterene—Asthenia—Valsartan—type 2 diabetes mellitus	0.000166	0.00196	CcSEcCtD
Triamterene—Asthenia—Orlistat—type 2 diabetes mellitus	0.000164	0.00194	CcSEcCtD
Triamterene—Dry mouth—Ramipril—type 2 diabetes mellitus	0.000164	0.00193	CcSEcCtD
Triamterene—CYP1A2—Fatty Acid Omega Oxidation—CYP2E1—type 2 diabetes mellitus	0.000162	0.00287	CbGpPWpGaD
Triamterene—Fatigue—Losartan—type 2 diabetes mellitus	0.000162	0.0019	CcSEcCtD
Triamterene—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.000161	0.00189	CcSEcCtD
Triamterene—Vomiting—Gliclazide—type 2 diabetes mellitus	0.00016	0.00189	CcSEcCtD
Triamterene—Rash—Gliclazide—type 2 diabetes mellitus	0.000159	0.00187	CcSEcCtD
Triamterene—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000159	0.00187	CcSEcCtD
Triamterene—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000159	0.00187	CcSEcCtD
Triamterene—Headache—Gliclazide—type 2 diabetes mellitus	0.000158	0.00186	CcSEcCtD
Triamterene—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	0.000157	0.00185	CcSEcCtD
Triamterene—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000157	0.00185	CcSEcCtD
Triamterene—CYP1A2—Fatty Acid Omega Oxidation—CYP3A4—type 2 diabetes mellitus	0.000157	0.00277	CbGpPWpGaD
Triamterene—Dizziness—Valsartan—type 2 diabetes mellitus	0.000153	0.00181	CcSEcCtD
Triamterene—Dizziness—Orlistat—type 2 diabetes mellitus	0.000152	0.00178	CcSEcCtD
Triamterene—Asthenia—Metformin—type 2 diabetes mellitus	0.000152	0.00178	CcSEcCtD
Triamterene—Nausea—Gliclazide—type 2 diabetes mellitus	0.00015	0.00177	CcSEcCtD
Triamterene—SCNN1B—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	0.000148	0.00261	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	0.000148	0.00261	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	0.000148	0.00261	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	0.000148	0.00261	CbGpPWpGaD
Triamterene—Vomiting—Valsartan—type 2 diabetes mellitus	0.000147	0.00174	CcSEcCtD
Triamterene—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000147	0.00173	CcSEcCtD
Triamterene—Rash—Valsartan—type 2 diabetes mellitus	0.000146	0.00172	CcSEcCtD
Triamterene—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000146	0.00172	CcSEcCtD
Triamterene—Vomiting—Orlistat—type 2 diabetes mellitus	0.000146	0.00172	CcSEcCtD
Triamterene—Headache—Valsartan—type 2 diabetes mellitus	0.000145	0.00171	CcSEcCtD
Triamterene—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000144	0.0017	CcSEcCtD
Triamterene—Rash—Orlistat—type 2 diabetes mellitus	0.000144	0.0017	CcSEcCtD
Triamterene—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000144	0.0017	CcSEcCtD
Triamterene—Headache—Orlistat—type 2 diabetes mellitus	0.000144	0.00169	CcSEcCtD
Triamterene—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000143	0.00168	CcSEcCtD
Triamterene—CYP1A2—Estrogen metabolism—CYP3A4—type 2 diabetes mellitus	0.000142	0.00252	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	0.000141	0.00249	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	0.000141	0.00249	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	0.000141	0.00249	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	0.000141	0.00249	CbGpPWpGaD
Triamterene—Dizziness—Metformin—type 2 diabetes mellitus	0.00014	0.00164	CcSEcCtD
Triamterene—Fatigue—Ramipril—type 2 diabetes mellitus	0.000139	0.00163	CcSEcCtD
Triamterene—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000138	0.00163	CcSEcCtD
Triamterene—Nausea—Valsartan—type 2 diabetes mellitus	0.000138	0.00162	CcSEcCtD
Triamterene—CYP1A2—Aflatoxin activation and detoxification—CYP3A4—type 2 diabetes mellitus	0.000136	0.00241	CbGpPWpGaD
Triamterene—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000136	0.00161	CcSEcCtD
Triamterene—Nausea—Orlistat—type 2 diabetes mellitus	0.000136	0.0016	CcSEcCtD
Triamterene—CYP1A2—Xenobiotics—CYP2E1—type 2 diabetes mellitus	0.000136	0.0024	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	0.000135	0.00239	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	0.000135	0.00239	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	0.000135	0.00239	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	0.000135	0.00239	CbGpPWpGaD
Triamterene—Asthenia—Losartan—type 2 diabetes mellitus	0.000135	0.00158	CcSEcCtD
Triamterene—Vomiting—Metformin—type 2 diabetes mellitus	0.000134	0.00158	CcSEcCtD
Triamterene—Rash—Metformin—type 2 diabetes mellitus	0.000133	0.00157	CcSEcCtD
Triamterene—Dermatitis—Metformin—type 2 diabetes mellitus	0.000133	0.00157	CcSEcCtD
Triamterene—Headache—Metformin—type 2 diabetes mellitus	0.000132	0.00156	CcSEcCtD
Triamterene—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000132	0.00155	CcSEcCtD
Triamterene—CYP1A2—Xenobiotics—CYP3A4—type 2 diabetes mellitus	0.000131	0.00232	CbGpPWpGaD
Triamterene—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—type 2 diabetes mellitus	0.000131	0.00231	CbGpPWpGaD
Triamterene—CYP1A2—Tamoxifen metabolism—CYP2E1—type 2 diabetes mellitus	0.000131	0.00231	CbGpPWpGaD
Triamterene—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000128	0.00151	CcSEcCtD
Triamterene—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000127	0.00149	CcSEcCtD
Triamterene—CYP1A2—Estrogen Receptor Pathway—PPARA—type 2 diabetes mellitus	0.000126	0.00223	CbGpPWpGaD
Triamterene—CYP1A2—Tamoxifen metabolism—CYP3A4—type 2 diabetes mellitus	0.000126	0.00223	CbGpPWpGaD
Triamterene—Rash—Irbesartan—type 2 diabetes mellitus	0.000126	0.00148	CcSEcCtD
Triamterene—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000126	0.00148	CcSEcCtD
Triamterene—Nausea—Metformin—type 2 diabetes mellitus	0.000125	0.00148	CcSEcCtD
Triamterene—Headache—Irbesartan—type 2 diabetes mellitus	0.000125	0.00147	CcSEcCtD
Triamterene—Dizziness—Losartan—type 2 diabetes mellitus	0.000124	0.00146	CcSEcCtD
Triamterene—Vomiting—Losartan—type 2 diabetes mellitus	0.000119	0.0014	CcSEcCtD
Triamterene—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000118	0.0014	CcSEcCtD
Triamterene—Nausea—Irbesartan—type 2 diabetes mellitus	0.000118	0.00139	CcSEcCtD
Triamterene—Rash—Losartan—type 2 diabetes mellitus	0.000118	0.00139	CcSEcCtD
Triamterene—Dermatitis—Losartan—type 2 diabetes mellitus	0.000118	0.00139	CcSEcCtD
Triamterene—Headache—Losartan—type 2 diabetes mellitus	0.000117	0.00138	CcSEcCtD
Triamterene—SCNN1G—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	0.000116	0.00206	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	0.000116	0.00206	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	0.000116	0.00206	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	0.000116	0.00206	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	0.000116	0.00205	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	0.000116	0.00205	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	0.000116	0.00205	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	0.000116	0.00205	CbGpPWpGaD
Triamterene—Asthenia—Ramipril—type 2 diabetes mellitus	0.000115	0.00136	CcSEcCtD
Triamterene—SCNN1A—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	0.000115	0.00203	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	0.000115	0.00203	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	0.000115	0.00203	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	0.000115	0.00203	CbGpPWpGaD
Triamterene—CYP1A2—Estrogen metabolism—GSTM1—type 2 diabetes mellitus	0.000112	0.00198	CbGpPWpGaD
Triamterene—Nausea—Losartan—type 2 diabetes mellitus	0.000111	0.00131	CcSEcCtD
Triamterene—SCNN1B—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	0.000111	0.00196	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	0.000111	0.00196	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	0.000111	0.00196	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	0.000111	0.00196	CbGpPWpGaD
Triamterene—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.00011	0.0013	CcSEcCtD
Triamterene—Dizziness—Ramipril—type 2 diabetes mellitus	0.000106	0.00125	CcSEcCtD
Triamterene—SCNN1G—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	0.000104	0.00184	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	0.000104	0.00184	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	0.000104	0.00184	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	0.000104	0.00184	CbGpPWpGaD
Triamterene—CYP1A2—Phase II conjugation—MAT1A—type 2 diabetes mellitus	0.000102	0.00181	CbGpPWpGaD
Triamterene—Vomiting—Ramipril—type 2 diabetes mellitus	0.000102	0.0012	CcSEcCtD
Triamterene—Rash—Ramipril—type 2 diabetes mellitus	0.000101	0.00119	CcSEcCtD
Triamterene—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000101	0.00119	CcSEcCtD
Triamterene—Headache—Ramipril—type 2 diabetes mellitus	0.000101	0.00119	CcSEcCtD
Triamterene—Nausea—Ramipril—type 2 diabetes mellitus	9.55e-05	0.00112	CcSEcCtD
Triamterene—SCNN1G—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	9.36e-05	0.00166	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	9.36e-05	0.00166	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	9.36e-05	0.00166	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	9.36e-05	0.00166	CbGpPWpGaD
Triamterene—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—type 2 diabetes mellitus	8.88e-05	0.00157	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	8.78e-05	0.00155	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	8.78e-05	0.00155	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	8.78e-05	0.00155	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	8.78e-05	0.00155	CbGpPWpGaD
Triamterene—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—type 2 diabetes mellitus	8.56e-05	0.00151	CbGpPWpGaD
Triamterene—CYP1A2—Melatonin metabolism and effects—EDN1—type 2 diabetes mellitus	7.73e-05	0.00137	CbGpPWpGaD
Triamterene—CYP1A2—Tryptophan metabolism—CYP2E1—type 2 diabetes mellitus	6.97e-05	0.00123	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	6.96e-05	0.00123	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	6.96e-05	0.00123	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	6.96e-05	0.00123	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	6.96e-05	0.00123	CbGpPWpGaD
Triamterene—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP11A1—type 2 diabetes mellitus	6.83e-05	0.00121	CbGpPWpGaD
Triamterene—CYP1A2—Oxidation by Cytochrome P450—CYP11A1—type 2 diabetes mellitus	6.74e-05	0.00119	CbGpPWpGaD
Triamterene—CYP1A2—Tryptophan metabolism—CYP3A4—type 2 diabetes mellitus	6.73e-05	0.00119	CbGpPWpGaD
Triamterene—CYP1A2—Melatonin metabolism and effects—CALM1—type 2 diabetes mellitus	6.31e-05	0.00112	CbGpPWpGaD
Triamterene—CYP1A2—Melatonin metabolism and effects—APOE—type 2 diabetes mellitus	6.29e-05	0.00111	CbGpPWpGaD
Triamterene—CYP1A2—Biological oxidations—MAT1A—type 2 diabetes mellitus	5.99e-05	0.00106	CbGpPWpGaD
Triamterene—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—type 2 diabetes mellitus	5.84e-05	0.00103	CbGpPWpGaD
Triamterene—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2E1—type 2 diabetes mellitus	5.64e-05	0.000997	CbGpPWpGaD
Triamterene—CYP1A2—Tryptophan metabolism—CAT—type 2 diabetes mellitus	5.6e-05	0.00099	CbGpPWpGaD
Triamterene—CYP1A2—Oxidation by Cytochrome P450—CYP2E1—type 2 diabetes mellitus	5.56e-05	0.000984	CbGpPWpGaD
Triamterene—CYP1A2—Phase 1 - Functionalization of compounds—CYP11A1—type 2 diabetes mellitus	5.54e-05	0.000979	CbGpPWpGaD
Triamterene—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP3A4—type 2 diabetes mellitus	5.44e-05	0.000962	CbGpPWpGaD
Triamterene—CYP1A2—Oxidation by Cytochrome P450—CYP3A4—type 2 diabetes mellitus	5.37e-05	0.000949	CbGpPWpGaD
Triamterene—CYP1A2—Phase II conjugation—MTR—type 2 diabetes mellitus	5.19e-05	0.000918	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—LPL—type 2 diabetes mellitus	5.19e-05	0.000918	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—CD36—type 2 diabetes mellitus	4.93e-05	0.000872	CbGpPWpGaD
Triamterene—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—type 2 diabetes mellitus	4.82e-05	0.000853	CbGpPWpGaD
Triamterene—CYP1A2—Arachidonic acid metabolism—GPX1—type 2 diabetes mellitus	4.74e-05	0.000837	CbGpPWpGaD
Triamterene—CYP1A2—Phase 1 - Functionalization of compounds—CYP2E1—type 2 diabetes mellitus	4.57e-05	0.000809	CbGpPWpGaD
Triamterene—CYP1A2—Phase 1 - Functionalization of compounds—CYP3A4—type 2 diabetes mellitus	4.41e-05	0.00078	CbGpPWpGaD
Triamterene—CYP1A2—Melatonin metabolism and effects—NFKB1—type 2 diabetes mellitus	3.74e-05	0.000662	CbGpPWpGaD
Triamterene—CYP1A2—Phase II conjugation—GSTM1—type 2 diabetes mellitus	3.15e-05	0.000556	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—RELA—type 2 diabetes mellitus	3.07e-05	0.000542	CbGpPWpGaD
Triamterene—CYP1A2—Biological oxidations—MTR—type 2 diabetes mellitus	3.04e-05	0.000537	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—type 2 diabetes mellitus	2.98e-05	0.000527	CbGpPWpGaD
Triamterene—CYP1A2—Biological oxidations—CYP11A1—type 2 diabetes mellitus	2.94e-05	0.00052	CbGpPWpGaD
Triamterene—CYP1A2—Metapathway biotransformation—CYP11A1—type 2 diabetes mellitus	2.9e-05	0.000513	CbGpPWpGaD
Triamterene—CYP1A2—Arachidonic acid metabolism—PTGS2—type 2 diabetes mellitus	2.79e-05	0.000493	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—PTGDS—type 2 diabetes mellitus	2.75e-05	0.000487	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—GPD2—type 2 diabetes mellitus	2.61e-05	0.000462	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—type 2 diabetes mellitus	2.59e-05	0.000457	CbGpPWpGaD
Triamterene—CYP1A2—Biological oxidations—CYP2E1—type 2 diabetes mellitus	2.43e-05	0.000429	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—type 2 diabetes mellitus	2.41e-05	0.000426	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—SRC—type 2 diabetes mellitus	2.41e-05	0.000426	CbGpPWpGaD
Triamterene—CYP1A2—Metapathway biotransformation—CYP2E1—type 2 diabetes mellitus	2.39e-05	0.000424	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—type 2 diabetes mellitus	2.35e-05	0.000415	CbGpPWpGaD
Triamterene—CYP1A2—Biological oxidations—CYP3A4—type 2 diabetes mellitus	2.34e-05	0.000414	CbGpPWpGaD
Triamterene—CYP1A2—Metapathway biotransformation—CYP3A4—type 2 diabetes mellitus	2.31e-05	0.000408	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—type 2 diabetes mellitus	2.15e-05	0.000381	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—type 2 diabetes mellitus	2.11e-05	0.000374	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—type 2 diabetes mellitus	2.11e-05	0.000374	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—OXCT1—type 2 diabetes mellitus	2.03e-05	0.000359	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—type 2 diabetes mellitus	2.01e-05	0.000356	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—TNF—type 2 diabetes mellitus	2.01e-05	0.000356	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—SRD5A1—type 2 diabetes mellitus	1.98e-05	0.00035	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—HSD17B3—type 2 diabetes mellitus	1.89e-05	0.000334	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—STAR—type 2 diabetes mellitus	1.89e-05	0.000334	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—ACACA—type 2 diabetes mellitus	1.89e-05	0.000334	CbGpPWpGaD
Triamterene—CYP1A2—Biological oxidations—GSTM1—type 2 diabetes mellitus	1.84e-05	0.000325	CbGpPWpGaD
Triamterene—CYP1A2—Metapathway biotransformation—GSTM1—type 2 diabetes mellitus	1.81e-05	0.000321	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—NCOA6—type 2 diabetes mellitus	1.71e-05	0.000303	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—HSD11B1—type 2 diabetes mellitus	1.68e-05	0.000298	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—HSD3B2—type 2 diabetes mellitus	1.43e-05	0.000253	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—LPA—type 2 diabetes mellitus	1.43e-05	0.000253	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—BHMT—type 2 diabetes mellitus	1.4e-05	0.000248	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—AANAT—type 2 diabetes mellitus	1.23e-05	0.000217	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—PTGDS—type 2 diabetes mellitus	1.23e-05	0.000217	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—CPT1A—type 2 diabetes mellitus	1.17e-05	0.000206	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—CDO1—type 2 diabetes mellitus	1.16e-05	0.000206	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—GPD2—type 2 diabetes mellitus	1.16e-05	0.000206	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—LIPC—type 2 diabetes mellitus	1.14e-05	0.000201	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—type 2 diabetes mellitus	1.13e-05	0.0002	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—AK1—type 2 diabetes mellitus	1.11e-05	0.000196	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—CETP—type 2 diabetes mellitus	1.1e-05	0.000194	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—MAT1A—type 2 diabetes mellitus	1.02e-05	0.000181	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—SLC5A4—type 2 diabetes mellitus	1.02e-05	0.000181	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—SREBF1—type 2 diabetes mellitus	1.02e-05	0.00018	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—type 2 diabetes mellitus	1e-05	0.000177	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—HMGCR—type 2 diabetes mellitus	9.92e-06	0.000175	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—HBA2—type 2 diabetes mellitus	9.89e-06	0.000175	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—ENPP1—type 2 diabetes mellitus	9.89e-06	0.000175	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—G6PC—type 2 diabetes mellitus	9.89e-06	0.000175	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—ND1—type 2 diabetes mellitus	9.89e-06	0.000175	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—PPP1R3C—type 2 diabetes mellitus	9.89e-06	0.000175	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—GCGR—type 2 diabetes mellitus	9.58e-06	0.000169	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—OXCT1—type 2 diabetes mellitus	9.04e-06	0.00016	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—CYTB—type 2 diabetes mellitus	9.04e-06	0.00016	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—SRD5A1—type 2 diabetes mellitus	8.81e-06	0.000156	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—STAR—type 2 diabetes mellitus	8.41e-06	0.000149	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—ACACA—type 2 diabetes mellitus	8.41e-06	0.000149	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—HSD17B3—type 2 diabetes mellitus	8.41e-06	0.000149	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—ABCC8—type 2 diabetes mellitus	8.06e-06	0.000143	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—CBS—type 2 diabetes mellitus	8.06e-06	0.000143	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—SLC5A2—type 2 diabetes mellitus	7.76e-06	0.000137	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—COX2—type 2 diabetes mellitus	7.76e-06	0.000137	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—NCOA6—type 2 diabetes mellitus	7.62e-06	0.000135	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	7.62e-06	0.000135	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—HSD11B1—type 2 diabetes mellitus	7.49e-06	0.000133	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—UCP3—type 2 diabetes mellitus	7.49e-06	0.000133	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—UCP2—type 2 diabetes mellitus	7.49e-06	0.000133	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	7.26e-06	0.000128	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—PCK1—type 2 diabetes mellitus	7.05e-06	0.000125	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	6.94e-06	0.000123	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	6.77e-06	0.00012	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—HK1—type 2 diabetes mellitus	6.6e-06	0.000117	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	6.59e-06	0.000117	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—KCNJ11—type 2 diabetes mellitus	6.37e-06	0.000113	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—HSD3B2—type 2 diabetes mellitus	6.37e-06	0.000113	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—LPA—type 2 diabetes mellitus	6.37e-06	0.000113	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—GCKR—type 2 diabetes mellitus	6.37e-06	0.000113	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	6.13e-06	0.000108	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—ALDOB—type 2 diabetes mellitus	6.11e-06	0.000108	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	5.93e-06	0.000105	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	5.81e-06	0.000103	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	5.75e-06	0.000102	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—GLP1R—type 2 diabetes mellitus	5.68e-06	0.0001	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—SLC2A2—type 2 diabetes mellitus	5.3e-06	9.38e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—CPT1A—type 2 diabetes mellitus	5.19e-06	9.19e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—MTR—type 2 diabetes mellitus	5.19e-06	9.19e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—NAMPT—type 2 diabetes mellitus	5.09e-06	9.01e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	5.06e-06	8.96e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—HBA1—type 2 diabetes mellitus	5.06e-06	8.95e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—LIPC—type 2 diabetes mellitus	5.06e-06	8.95e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—GCK—type 2 diabetes mellitus	5.06e-06	8.95e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—CYP11A1—type 2 diabetes mellitus	5.03e-06	8.9e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—SLC9A1—type 2 diabetes mellitus	4.94e-06	8.74e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—CETP—type 2 diabetes mellitus	4.88e-06	8.64e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	4.55e-06	8.05e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—PSMD6—type 2 diabetes mellitus	4.54e-06	8.03e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—SREBF1—type 2 diabetes mellitus	4.54e-06	8.03e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—SNAP25—type 2 diabetes mellitus	4.54e-06	8.03e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—CTGF—type 2 diabetes mellitus	4.46e-06	7.88e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—HMGCR—type 2 diabetes mellitus	4.42e-06	7.81e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	4.36e-06	7.7e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—ADRA2A—type 2 diabetes mellitus	4.32e-06	7.64e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—CYP2E1—type 2 diabetes mellitus	4.15e-06	7.34e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—SLC2A1—type 2 diabetes mellitus	4.11e-06	7.26e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—CYP3A4—type 2 diabetes mellitus	4e-06	7.08e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	3.98e-06	7.05e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—SLC2A4—type 2 diabetes mellitus	3.94e-06	6.96e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—GCG—type 2 diabetes mellitus	3.94e-06	6.96e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—GNB3—type 2 diabetes mellitus	3.39e-06	6e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.39e-06	6e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—HMOX1—type 2 diabetes mellitus	3.38e-06	5.97e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—CAT—type 2 diabetes mellitus	3.33e-06	5.89e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—APOB—type 2 diabetes mellitus	3.24e-06	5.72e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—GSTM1—type 2 diabetes mellitus	3.15e-06	5.57e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—LPL—type 2 diabetes mellitus	3.09e-06	5.46e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—ADCY5—type 2 diabetes mellitus	3.02e-06	5.35e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—GPX1—type 2 diabetes mellitus	3.01e-06	5.33e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—CD36—type 2 diabetes mellitus	2.94e-06	5.19e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	2.9e-06	5.13e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—MTHFR—type 2 diabetes mellitus	2.78e-06	4.92e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—PPARA—type 2 diabetes mellitus	2.73e-06	4.83e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—AGT—type 2 diabetes mellitus	2.64e-06	4.67e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—CALM1—type 2 diabetes mellitus	2.6e-06	4.6e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—APOE—type 2 diabetes mellitus	2.59e-06	4.58e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—APOA1—type 2 diabetes mellitus	2.56e-06	4.53e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—PPARG—type 2 diabetes mellitus	2.26e-06	3.99e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—INS—type 2 diabetes mellitus	2.21e-06	3.91e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—ALB—type 2 diabetes mellitus	2.03e-06	3.59e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	1.94e-06	3.43e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—NOS3—type 2 diabetes mellitus	1.94e-06	3.43e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—PTGS2—type 2 diabetes mellitus	1.77e-06	3.14e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—AKT1—type 2 diabetes mellitus	8.92e-07	1.58e-05	CbGpPWpGaD
